A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer
| Autor: | Jung, Lindsey, Miske, Abby, Indorf, Amy, Nelson, Kate, Gadi, Vijayakrishna K, Banda, Kalyan |
|---|---|
| Zdroj: | In Clinical Breast Cancer April 2022 22(3):e310-e318 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect